CompleteSE Medtronic

COMPLETE PERFORMANCE

ORDER INFORMATION

SUPERIOR RADIAL FORCE WITHOUT SACRIFICING CONFORMABILITY*

SC 6 20 LG

5.0

5.46 4.61

8mm x 80 mm

8mm x 100 mm 5.16

5.13

Retractable sheath

5.08 4.55

4.15

4.0

3.60

Radiopaque markers

Stabilizing sheath

3.62 2.69

3.0

Stent Diameter (mm)

2.0 1.0 0.0 Medtronic Cordis Complete Smart® SE Control®

Bard LifeStent®

Medtronic Complete SE

Cook Zilver® 635

Bard LifeStent

Medtronic Complete SE

Cordis Smart Control

Abbott ev3 Absolute Protégé® Pro® EverFlex®

Testing was performed with a flat-plate crush to 30% of labeled nominal stent diameter.

OPTIMISED CELL DESIGN FOR KINK RESISTANCE AND FLEXIBILITY *

Stent Length (mm) 20

30

40

60

80

100

120

150

Catheter Minimum Working Sheath Length Size (F) (cm)

4

SC420LG

SC430LG

SC440LG

­—

—

—

—

—

6

130

5

SC520LG

SC530LG

SC540LG

SC560LG

SC580LG

SC5100LG

SC5120LG

SC5150LG

6

130

6

SC620LG

­­—

SC640LG

SC660LG

SC680LG

SC6100LG

SC6120LG

SC6150LG

6

130

7

SC720LG

—

SC740LG

SC760LG

SC780LG

SC7100LG

SC7120LG

SC7150LG

6

130

8

SC820LG

—

SC840LG

SC860LG

SC880LG

SC8100LG

SC8120LG

SC8150LG

6

130

9

SC920LG

—

SC940LG

SC960LG

SC980LG

—

—

—

6

130

10

SC1020LG

—

SC1040LG

SC1060LG

SC1080LG

—

—

—

6

130

Stent Diameter (mm)

Stent Length (mm) 150

Catheter Minimum Working Sheath Length Size (F) (cm)

20

30

40

60

80

100

120

4

SC420FG

SC430FG

SC440FG

­—

—

—

—

—

6

80

5

SC520FG

SC530FG

SC540FG

SC560FG

SC580FG

SC5100FG

SC5120FG

SC5150FG

6

80

6

SC620FG

­­—

SC640FG

SC660FG

SC680FG

SC6100FG

SC6120FG

SC6150FG

6

80

7

SC720FG

—

SC740FG

SC760FG

SC780FG

SC7100FG

SC7120FG

SC7150FG

6

80

8

SC820FG

—

SC840FG

SC860FG

SC880FG

SC8100FG

SC8120FG

SC8150FG

6

80

9

SC920FG

—

SC940FG

SC960FG

SC980FG

—

—

—

6

80

10

SC1020FG

—

SC1040FG

SC1060FG

SC1080FG

—

—

—

6

80

The Complete SE stent is MRI conditional. The Complete SE Vascular Self-Expanding Stent System is indicated to improve luminal diameter in symptomatic patients with previously unstented iliac stenosis in the common and external iliac arteries or atherosclerotic lesions of the Superficial Femoral Artery (SFA) or Proximal Popliteal Artery (PPA) with vessel reference diameters between 3.5 mm and 9.0 mm.

Warning: Please reference appropriate product Instructions for Use for a list of indications, warnings, precautions and potential adverse event

Offset crown design minimises crown-tocrown interaction while bending

NOW APPROVED For SFA/PPA

SELF-EXPANDING STENT SYSTEM

Dual-deployment handle

Three different segment lengths allow consistent behavior across all diameters: • M inimal foreshortening • E xcellent flexibility

* Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance.

Tested in multimode conditions representative of the iliac, superficial femoral and proximal popliteal arteries to substantiate long-term performance

www.medtronicendovascular.com www.medtronic.eu Invatec S.p.A. Via Martiri della Libertà 7 25030 Roncadelle (BS) Italy Tel: +39.030.2589311

INVATEC Technology Center GmbH Hungerbüelstrasse 12a 8500 Frauenfeld Switzerland Tel: +41.52.2600660

Medtronic, Inc. 710 Medtronic Parkway NE Minneapolis, MN 55432 USA Tel: +1.763.514.4000

Medtronic International Trading Sàrl Route du Molliau 31 CH-1131 Tolochenaz Switzerland Tel: +41.21.802.7000

Medtronic of Canada Ltd. 99 Hereford Street Brampton, Ontario L6Y 0R3 Canada Tel: +1.905.460.3800

Medtronic Latin America 3750 NW 87th Avenue, Suite 700 Miami, FL 33178 USA Tel: +1.786.709.4200

Medtronic International Ltd. 49 Changi South Avenue 2 Singapore 486056 Tel: +65.6436.5000

Medtronic Australasia Pty Ltd. 97 Waterloo Road North Ryde, NSW 2113 Australia Tel: +61.29857.9000

Medtronic Korea Co., Ltd. 5F, Sajo Building 1001 Daechi-dong, Kangnam-ku Seoul, 135-280 Korea Tel: +82.2.3404.3600

Medtronic Mediterranean S.A.L. St. Charles City Center 6th Floor, Omar Doauk Street Beirut 2020-0908 Lebanon Tel: +961.1.370670

UC201300554 EE © 2013 Medtronic, Inc. All rights reserved. Not for distribution in the USA . 01/13

Mean Radial Force (N)

6.0

Atraumatic tip

Catheter Working Length Length (F = 80, L = 130) Diameter Product Code

RADIAL FORCE 7mm x 100 mm

Complete SE Vascular ™

Complete™ SE Vascular Product Code

Complete Performance CONTROL. COMMITMENT. CONFIDENCE.

Innovating for life.

COMPLETE CONTROL

COMPLETE COMMITMENT

COMPLETE CONFIDENCE

DEPLOYMENT AND ACCURACY MADE EASY

APPROVED FOR ILIAC ARTERY, SFA AND PPA

FEWEST REINTERVENTIONS IN THE SFA*

Medtronic and physicians alike are committed to improving patients’ lives. We pursue this mission, in part, by arming healthcare providers with clinical data they need to practice evidence-centered medicine. Complete® SE embodies this commitment with continued follow-up in clinical trials that capture the device’s safety and efficacy in the iliac, superficial femoral and proximal popliteal arteries.

An independently adjudicated single-arm multicenter trial evaluated the performance of Complete® SE for the treatment of atherosclerotic lesions of the superficial femoral and proximal popliteal arteries. A representative population comprised of 196 subjects was enrolled with results compared with VIVA Performance Goals.†

The Complete® SE 6 F delivery system’s unique design incorporates a dual deployment handle and a triaxial catheter. The dual deployment handle is intuitive and easy to use, giving you the ultimate control during deployment while the triaxial catheter minimises unexpected jumping.*

TLR rate

8.4% at 12 months††

PATIENT DEMOGRAPHICS N = 196

Dual Deployment Handle*

%

Age

68.7 ± 10.5

Male

63.3

Diabetes mellitus

45.4

Dyslipidemia

79.6

Hypertension

90.3

History of tobacco use

79.6

History of CAD

62.8

History of COPD

21.4

Previous MI

26.2

%

(m/n)3

Total lesion length (n = 213)2 (mm)

60.7

± 37.62

Total occlusion

29.9

(60/201)

Distal SFA/PPA

49.7

(106/213)

Mid SFA

34.3

(73/213)

Proximal SFA

16.0

(34/213)

Severe

56.2

(118/210)

Moderate

34.8

(73/210)

None/mild

9.0

(19/210)

LESION MORPHOLOGY1 1. R otate the handle to retract the sheath slowly and allow the stent to expand in a precisely controlled manner.†

Triaxial Catheter

2. O nce the stent is properly positioned, complete the deployment by simply pushing the buttons and pulling back the handle in one fluid motion.

ISIS-SE Study

12-month MAE TVR TLR The delivery system’s triaxial design includes an inner shaft, a retractable sheath and a stabilising sheath.

Retractable sheath

Complete SE Iliac Registry 3.3% 2.1% 2.1%

(n = 158)

Complete SE SFA Study

9-month MAE TVR TLR

9.4% 9.4% 3.8%

(n = 55)

12-month MAE TVR TLR

(n = 196)

BINARY TRIAL ENDPOINT ††

2002

2005

2011

Inner shaft The stabilising sheath reduces friction and allows the retractable sheath to move back freely. This decreases the amount of force required to deploy the stent, making deployment easy and accurate. * Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance. † Data on file

Calcification

11.0% 11.0% 8.4%

%

MAE at 12 months

11.0

TVR

11.0

TLR

8.4

PRIMARY EFFICACY ENDPOINT * Compared with SFA studies of Cook Zilver PTX, IDEV SUPERA, Cordis Smart Stent, Bard Lifestent and EV3 Protégé Everflex. † Rocha-Singh K et al. Catheter Cardiovasc Interv. 2007;69:910-919. †† Reference Complete SE SFA Study - Clinically Driven TLR rate.

1 Independently adjudicated by core lab.

2 Lesions as reported by the Angiographic Core Laboratory.

3 Based on number of lesions with available data.

Primary patency (PSVR < 2.0)

72.6

COMPLETE CONTROL

COMPLETE COMMITMENT

COMPLETE CONFIDENCE

DEPLOYMENT AND ACCURACY MADE EASY

APPROVED FOR ILIAC ARTERY, SFA AND PPA

FEWEST REINTERVENTIONS IN THE SFA*

Medtronic and physicians alike are committed to improving patients’ lives. We pursue this mission, in part, by arming healthcare providers with clinical data they need to practice evidence-centered medicine. Complete® SE embodies this commitment with continued follow-up in clinical trials that capture the device’s safety and efficacy in the iliac, superficial femoral and proximal popliteal arteries.

An independently adjudicated single-arm multicenter trial evaluated the performance of Complete® SE for the treatment of atherosclerotic lesions of the superficial femoral and proximal popliteal arteries. A representative population comprised of 196 subjects was enrolled with results compared with VIVA Performance Goals.†

The Complete® SE 6 F delivery system’s unique design incorporates a dual deployment handle and a triaxial catheter. The dual deployment handle is intuitive and easy to use, giving you the ultimate control during deployment while the triaxial catheter minimises unexpected jumping.*

TLR rate

8.4% at 12 months††

PATIENT DEMOGRAPHICS N = 196

Dual Deployment Handle*

%

Age

68.7 ± 10.5

Male

63.3

Diabetes mellitus

45.4

Dyslipidemia

79.6

Hypertension

90.3

History of tobacco use

79.6

History of CAD

62.8

History of COPD

21.4

Previous MI

26.2

%

(m/n)3

Total lesion length (n = 213)2 (mm)

60.7

± 37.62

Total occlusion

29.9

(60/201)

Distal SFA/PPA

49.7

(106/213)

Mid SFA

34.3

(73/213)

Proximal SFA

16.0

(34/213)

Severe

56.2

(118/210)

Moderate

34.8

(73/210)

None/mild

9.0

(19/210)

LESION MORPHOLOGY1 1. R otate the handle to retract the sheath slowly and allow the stent to expand in a precisely controlled manner.†

Triaxial Catheter

2. O nce the stent is properly positioned, complete the deployment by simply pushing the buttons and pulling back the handle in one fluid motion.

ISIS-SE Study

12-month MAE TVR TLR The delivery system’s triaxial design includes an inner shaft, a retractable sheath and a stabilising sheath.

Retractable sheath

Complete SE Iliac Registry 3.3% 2.1% 2.1%

(n = 158)

Complete SE SFA Study

9-month MAE TVR TLR

9.4% 9.4% 3.8%

(n = 55)

12-month MAE TVR TLR

(n = 196)

BINARY TRIAL ENDPOINT ††

2002

2005

2011

Inner shaft The stabilising sheath reduces friction and allows the retractable sheath to move back freely. This decreases the amount of force required to deploy the stent, making deployment easy and accurate. * Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance. † Data on file

Calcification

11.0% 11.0% 8.4%

%

MAE at 12 months

11.0

TVR

11.0

TLR

8.4

PRIMARY EFFICACY ENDPOINT * Compared with SFA studies of Cook Zilver PTX, IDEV SUPERA, Cordis Smart Stent, Bard Lifestent and EV3 Protégé Everflex. † Rocha-Singh K et al. Catheter Cardiovasc Interv. 2007;69:910-919. †† Reference Complete SE SFA Study - Clinically Driven TLR rate.

1 Independently adjudicated by core lab.

2 Lesions as reported by the Angiographic Core Laboratory.

3 Based on number of lesions with available data.

Primary patency (PSVR < 2.0)

72.6

COMPLETE CONTROL

COMPLETE COMMITMENT

COMPLETE CONFIDENCE

DEPLOYMENT AND ACCURACY MADE EASY

APPROVED FOR ILIAC ARTERY, SFA AND PPA

FEWEST REINTERVENTIONS IN THE SFA*

Medtronic and physicians alike are committed to improving patients’ lives. We pursue this mission, in part, by arming healthcare providers with clinical data they need to practice evidence-centered medicine. Complete® SE embodies this commitment with continued follow-up in clinical trials that capture the device’s safety and efficacy in the iliac, superficial femoral and proximal popliteal arteries.

An independently adjudicated single-arm multicenter trial evaluated the performance of Complete® SE for the treatment of atherosclerotic lesions of the superficial femoral and proximal popliteal arteries. A representative population comprised of 196 subjects was enrolled with results compared with VIVA Performance Goals.†

The Complete® SE 6 F delivery system’s unique design incorporates a dual deployment handle and a triaxial catheter. The dual deployment handle is intuitive and easy to use, giving you the ultimate control during deployment while the triaxial catheter minimises unexpected jumping.*

TLR rate

8.4% at 12 months††

PATIENT DEMOGRAPHICS N = 196

Dual Deployment Handle*

%

Age

68.7 ± 10.5

Male

63.3

Diabetes mellitus

45.4

Dyslipidemia

79.6

Hypertension

90.3

History of tobacco use

79.6

History of CAD

62.8

History of COPD

21.4

Previous MI

26.2

%

(m/n)3

Total lesion length (n = 213)2 (mm)

60.7

± 37.62

Total occlusion

29.9

(60/201)

Distal SFA/PPA

49.7

(106/213)

Mid SFA

34.3

(73/213)

Proximal SFA

16.0

(34/213)

Severe

56.2

(118/210)

Moderate

34.8

(73/210)

None/mild

9.0

(19/210)

LESION MORPHOLOGY1 1. R otate the handle to retract the sheath slowly and allow the stent to expand in a precisely controlled manner.†

Triaxial Catheter

2. O nce the stent is properly positioned, complete the deployment by simply pushing the buttons and pulling back the handle in one fluid motion.

ISIS-SE Study

12-month MAE TVR TLR The delivery system’s triaxial design includes an inner shaft, a retractable sheath and a stabilising sheath.

Retractable sheath

Complete SE Iliac Registry 3.3% 2.1% 2.1%

(n = 158)

Complete SE SFA Study

9-month MAE TVR TLR

9.4% 9.4% 3.8%

(n = 55)

12-month MAE TVR TLR

(n = 196)

BINARY TRIAL ENDPOINT ††

2002

2005

2011

Inner shaft The stabilising sheath reduces friction and allows the retractable sheath to move back freely. This decreases the amount of force required to deploy the stent, making deployment easy and accurate. * Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance. † Data on file

Calcification

11.0% 11.0% 8.4%

%

MAE at 12 months

11.0

TVR

11.0

TLR

8.4

PRIMARY EFFICACY ENDPOINT * Compared with SFA studies of Cook Zilver PTX, IDEV SUPERA, Cordis Smart Stent, Bard Lifestent and EV3 Protégé Everflex. † Rocha-Singh K et al. Catheter Cardiovasc Interv. 2007;69:910-919. †† Reference Complete SE SFA Study - Clinically Driven TLR rate.

1 Independently adjudicated by core lab.

2 Lesions as reported by the Angiographic Core Laboratory.

3 Based on number of lesions with available data.

Primary patency (PSVR < 2.0)

72.6

COMPLETE PERFORMANCE

ORDER INFORMATION

SUPERIOR RADIAL FORCE WITHOUT SACRIFICING CONFORMABILITY*

SC 6 20 LG

5.0

5.46 4.61

8mm x 80 mm

8mm x 100 mm 5.16

5.13

Retractable sheath

5.08 4.55

4.15

4.0

3.60

Radiopaque markers

Stabilizing sheath

3.62 2.69

3.0

Stent Diameter (mm)

2.0 1.0 0.0 Medtronic Cordis Complete Smart® SE Control®

Bard LifeStent®

Medtronic Complete SE

Cook Zilver® 635

Bard LifeStent

Medtronic Complete SE

Cordis Smart Control

Abbott ev3 Absolute Protégé® Pro® EverFlex®

Testing was performed with a flat-plate crush to 30% of labeled nominal stent diameter.

OPTIMISED CELL DESIGN FOR KINK RESISTANCE AND FLEXIBILITY *

Stent Length (mm) 20

30

40

60

80

100

120

150

Catheter Minimum Working Sheath Length Size (F) (cm)

4

SC420LG

SC430LG

SC440LG

­—

—

—

—

—

6

130

5

SC520LG

SC530LG

SC540LG

SC560LG

SC580LG

SC5100LG

SC5120LG

SC5150LG

6

130

6

SC620LG

­­—

SC640LG

SC660LG

SC680LG

SC6100LG

SC6120LG

SC6150LG

6

130

7

SC720LG

—

SC740LG

SC760LG

SC780LG

SC7100LG

SC7120LG

SC7150LG

6

130

8

SC820LG

—

SC840LG

SC860LG

SC880LG

SC8100LG

SC8120LG

SC8150LG

6

130

9

SC920LG

—

SC940LG

SC960LG

SC980LG

—

—

—

6

130

10

SC1020LG

—

SC1040LG

SC1060LG

SC1080LG

—

—

—

6

130

Stent Diameter (mm)

Stent Length (mm) 150

Catheter Minimum Working Sheath Length Size (F) (cm)

20

30

40

60

80

100

120

4

SC420FG

SC430FG

SC440FG

­—

—

—

—

—

6

80

5

SC520FG

SC530FG

SC540FG

SC560FG

SC580FG

SC5100FG

SC5120FG

SC5150FG

6

80

6

SC620FG

­­—

SC640FG

SC660FG

SC680FG

SC6100FG

SC6120FG

SC6150FG

6

80

7

SC720FG

—

SC740FG

SC760FG

SC780FG

SC7100FG

SC7120FG

SC7150FG

6

80

8

SC820FG

—

SC840FG

SC860FG

SC880FG

SC8100FG

SC8120FG

SC8150FG

6

80

9

SC920FG

—

SC940FG

SC960FG

SC980FG

—

—

—

6

80

10

SC1020FG

—

SC1040FG

SC1060FG

SC1080FG

—

—

—

6

80

The Complete SE stent is MRI conditional. The Complete SE Vascular Self-Expanding Stent System is indicated to improve luminal diameter in symptomatic patients with previously unstented iliac stenosis in the common and external iliac arteries or atherosclerotic lesions of the Superficial Femoral Artery (SFA) or Proximal Popliteal Artery (PPA) with vessel reference diameters between 3.5 mm and 9.0 mm.

Warning: Please reference appropriate product Instructions for Use for a list of indications, warnings, precautions and potential adverse event

Offset crown design minimises crown-tocrown interaction while bending

NOW APPROVED For SFA/PPA

SELF-EXPANDING STENT SYSTEM

Dual-deployment handle

Three different segment lengths allow consistent behavior across all diameters: • M inimal foreshortening • E xcellent flexibility

* Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance.

Tested in multimode conditions representative of the iliac, superficial femoral and proximal popliteal arteries to substantiate long-term performance

www.medtronicendovascular.com www.medtronic.eu Invatec S.p.A. Via Martiri della Libertà 7 25030 Roncadelle (BS) Italy Tel: +39.030.2589311

INVATEC Technology Center GmbH Hungerbüelstrasse 12a 8500 Frauenfeld Switzerland Tel: +41.52.2600660

Medtronic, Inc. 710 Medtronic Parkway NE Minneapolis, MN 55432 USA Tel: +1.763.514.4000

Medtronic International Trading Sàrl Route du Molliau 31 CH-1131 Tolochenaz Switzerland Tel: +41.21.802.7000

Medtronic of Canada Ltd. 99 Hereford Street Brampton, Ontario L6Y 0R3 Canada Tel: +1.905.460.3800

Medtronic Latin America 3750 NW 87th Avenue, Suite 700 Miami, FL 33178 USA Tel: +1.786.709.4200

Medtronic International Ltd. 49 Changi South Avenue 2 Singapore 486056 Tel: +65.6436.5000

Medtronic Australasia Pty Ltd. 97 Waterloo Road North Ryde, NSW 2113 Australia Tel: +61.29857.9000

Medtronic Korea Co., Ltd. 5F, Sajo Building 1001 Daechi-dong, Kangnam-ku Seoul, 135-280 Korea Tel: +82.2.3404.3600

Medtronic Mediterranean S.A.L. St. Charles City Center 6th Floor, Omar Doauk Street Beirut 2020-0908 Lebanon Tel: +961.1.370670

UC201300554 EE © 2013 Medtronic, Inc. All rights reserved. Not for distribution in the USA . 01/13

Mean Radial Force (N)

6.0

Atraumatic tip

Catheter Working Length Length (F = 80, L = 130) Diameter Product Code

RADIAL FORCE 7mm x 100 mm

Complete SE Vascular ™

Complete™ SE Vascular Product Code

Complete Performance CONTROL. COMMITMENT. CONFIDENCE.

Innovating for life.

COMPLETE PERFORMANCE

ORDER INFORMATION

SUPERIOR RADIAL FORCE WITHOUT SACRIFICING CONFORMABILITY*

SC 6 20 LG

5.0

5.46 4.61

8mm x 80 mm

8mm x 100 mm 5.16

5.13

Retractable sheath

5.08 4.55

4.15

4.0

3.60

Radiopaque markers

Stabilizing sheath

3.62 2.69

3.0

Stent Diameter (mm)

2.0 1.0 0.0 Medtronic Cordis Complete Smart® SE Control®

Bard LifeStent®

Medtronic Complete SE

Cook Zilver® 635

Bard LifeStent

Medtronic Complete SE

Cordis Smart Control

Abbott ev3 Absolute Protégé® Pro® EverFlex®

Testing was performed with a flat-plate crush to 30% of labeled nominal stent diameter.

OPTIMISED CELL DESIGN FOR KINK RESISTANCE AND FLEXIBILITY *

Stent Length (mm) 20

30

40

60

80

100

120

150

Catheter Minimum Working Sheath Length Size (F) (cm)

4

SC420LG

SC430LG

SC440LG

­—

—

—

—

—

6

130

5

SC520LG

SC530LG

SC540LG

SC560LG

SC580LG

SC5100LG

SC5120LG

SC5150LG

6

130

6

SC620LG

­­—

SC640LG

SC660LG

SC680LG

SC6100LG

SC6120LG

SC6150LG

6

130

7

SC720LG

—

SC740LG

SC760LG

SC780LG

SC7100LG

SC7120LG

SC7150LG

6

130

8

SC820LG

—

SC840LG

SC860LG

SC880LG

SC8100LG

SC8120LG

SC8150LG

6

130

9

SC920LG

—

SC940LG

SC960LG

SC980LG

—

—

—

6

130

10

SC1020LG

—

SC1040LG

SC1060LG

SC1080LG

—

—

—

6

130

Stent Diameter (mm)

Stent Length (mm) 150

Catheter Minimum Working Sheath Length Size (F) (cm)

20

30

40

60

80

100

120

4

SC420FG

SC430FG

SC440FG

­—

—

—

—

—

6

80

5

SC520FG

SC530FG

SC540FG

SC560FG

SC580FG

SC5100FG

SC5120FG

SC5150FG

6

80

6

SC620FG

­­—

SC640FG

SC660FG

SC680FG

SC6100FG

SC6120FG

SC6150FG

6

80

7

SC720FG

—

SC740FG

SC760FG

SC780FG

SC7100FG

SC7120FG

SC7150FG

6

80

8

SC820FG

—

SC840FG

SC860FG

SC880FG

SC8100FG

SC8120FG

SC8150FG

6

80

9

SC920FG

—

SC940FG

SC960FG

SC980FG

—

—

—

6

80

10

SC1020FG

—

SC1040FG

SC1060FG

SC1080FG

—

—

—

6

80

The Complete SE stent is MRI conditional. The Complete SE Vascular Self-Expanding Stent System is indicated to improve luminal diameter in symptomatic patients with previously unstented iliac stenosis in the common and external iliac arteries or atherosclerotic lesions of the Superficial Femoral Artery (SFA) or Proximal Popliteal Artery (PPA) with vessel reference diameters between 3.5 mm and 9.0 mm.

Warning: Please reference appropriate product Instructions for Use for a list of indications, warnings, precautions and potential adverse event

Offset crown design minimises crown-tocrown interaction while bending

NOW APPROVED For SFA/PPA

SELF-EXPANDING STENT SYSTEM

Dual-deployment handle

Three different segment lengths allow consistent behavior across all diameters: • M inimal foreshortening • E xcellent flexibility

* Test data on file at Medtronic, Inc. Benchtop data may not be indicative of clinical performance.

Tested in multimode conditions representative of the iliac, superficial femoral and proximal popliteal arteries to substantiate long-term performance

www.medtronicendovascular.com www.medtronic.eu Invatec S.p.A. Via Martiri della Libertà 7 25030 Roncadelle (BS) Italy Tel: +39.030.2589311

INVATEC Technology Center GmbH Hungerbüelstrasse 12a 8500 Frauenfeld Switzerland Tel: +41.52.2600660

Medtronic, Inc. 710 Medtronic Parkway NE Minneapolis, MN 55432 USA Tel: +1.763.514.4000

Medtronic International Trading Sàrl Route du Molliau 31 CH-1131 Tolochenaz Switzerland Tel: +41.21.802.7000

Medtronic of Canada Ltd. 99 Hereford Street Brampton, Ontario L6Y 0R3 Canada Tel: +1.905.460.3800

Medtronic Latin America 3750 NW 87th Avenue, Suite 700 Miami, FL 33178 USA Tel: +1.786.709.4200

Medtronic International Ltd. 49 Changi South Avenue 2 Singapore 486056 Tel: +65.6436.5000

Medtronic Australasia Pty Ltd. 97 Waterloo Road North Ryde, NSW 2113 Australia Tel: +61.29857.9000

Medtronic Korea Co., Ltd. 5F, Sajo Building 1001 Daechi-dong, Kangnam-ku Seoul, 135-280 Korea Tel: +82.2.3404.3600

Medtronic Mediterranean S.A.L. St. Charles City Center 6th Floor, Omar Doauk Street Beirut 2020-0908 Lebanon Tel: +961.1.370670

UC201300554 EE © 2013 Medtronic, Inc. All rights reserved. Not for distribution in the USA . 01/13

Mean Radial Force (N)

6.0

Atraumatic tip

Catheter Working Length Length (F = 80, L = 130) Diameter Product Code

RADIAL FORCE 7mm x 100 mm

Complete SE Vascular ™

Complete™ SE Vascular Product Code

Complete Performance CONTROL. COMMITMENT. CONFIDENCE.

Innovating for life.